Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M19.2Revenue (TTM) $M10.7Net Margin (%)150Altman Z-Score69.6
Enterprise Value $M6.3EPS (TTM) $0.4Operating Margin %78.3Piotroski F-Score5
P/E(ttm)1.2Beneish M-Score--Pre-tax Margin (%)78.3Higher ROA y-yY
Price/Book0.910-y EBITDA Growth Rate %--Quick Ratio80.6Cash flow > EarningsN
Price/Sales1.85-y EBITDA Growth Rate %--Current Ratio80.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-41.0ROA % (ttm)74.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)82.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M44.2ROIC % (ttm)260Gross Margin Increase y-yN

Gurus Latest Trades with ENZN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ENZNCarl Icahn 2016-06-30 Sold Out -0.01%$0.39 - $0.55
($0.45)
$ 0.44-2%Sold Out0
ENZNCarl Icahn 2011-09-30 Add0.07%$7.24 - $10.37
($8.8)
$ 0.44-95%Add 25.00%5,904,863
ENZNCarl Icahn 2010-12-31 Add0.41%$10.5 - $12.5
($11.36)
$ 0.44-96%Add 67.70%4,723,891
ENZNCarl Icahn 2009-03-31 Add0.09%$5.27 - $7.1
($6.1)
$ 0.44-93%Add 14.61%2,816,861
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ENZN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ENZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ICAHN CARL C10% Owner 2016-11-28Buy694,023$0.417.32view
LEBUHN ROBERTDirector 2013-09-19Sell55,926$1.72-74.42view
LEBUHN ROBERTDirector 2012-08-14Sell5,820$6.58-93.31view
LEBUHN ROBERTDirector 2012-08-10Sell1,933$6.58-93.31view
HEBARD GEORGEInterim PEO and Interim COO 2012-06-20Buy5,000$6.88-93.6view
Rackear Andrew D.VP and General Counsel 2012-06-05Sell1,614$6.81-93.54view
Conover CharlesSVP, R&D Program Management 2012-06-05Sell25,000$6.78-93.51view
Young Richard ADirector 2012-03-15Sell2,000$6.92-93.64view
Rackear Andrew D.VP and General Counsel 2011-11-10Sell3,766$6.68-93.41view
Buchbinder AbyVP, Clinical Development 2011-11-08Sell2,700$7.06-93.77view

Quarterly/Annual Reports about ENZN:

News about ENZN:

Articles On GuruFocus.com
Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals Dec 02 2016 
Top Micro-Cap Picks From the Gurus Jun 23 2015 
Baupost’s Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals May 12 2014 
GuruFocus Real Time Picks of the Week Jan 10 2014 
Seth Klarman Buys New Stock Kindred Biosciences, Cut Stake in Enzon Jan 10 2014 
Billionaires Hold Bargains, 40% Off or More Sep 11 2013 
Charles Brandes Top Second Quarter Portfolio Changes Aug 09 2013 
First Pacific Advisors’ Top New Buys Aug 08 2012 
Enzon Inc. Reports Operating Results (10-K) Mar 16 2011 
Carl Icahn Buys NAV, CHK, ENZN, AMLN, CMC, Feb 15 2011 

More From Other Websites
Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals Dec 02 2016
ENZON PHARMACEUTICALS, INC. Financials Nov 18 2016
ENZON PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events Nov 15 2016
Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016 Nov 14 2016
ENZON PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Nov 10 2016
ENZON PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events Oct 26 2016
Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 Aug 12 2016
OTC Markets Group Welcomes Enzon Pharmaceuticals, Inc. to OTCQX Aug 10 2016
ENZON PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Aug 10 2016
ENZON PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events Aug 09 2016
OTC Markets Group Welcomes Enzon Pharmaceuticals, Inc. to OTCQX Aug 09 2016
ENZON PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders,... Jul 05 2016
Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 May 26 2016
ENZON PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... May 16 2016
ENZON PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 09 2016
Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: 2015 By the Numbers Mar 24 2016
ENZON PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other... Mar 21 2016
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events Feb 23 2016
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Feb 09 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of... Jan 27 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)